Study has implications beyond medical education, suggesting other fields could benefit from AI-enhanced training...
Since becoming only the second Alzheimer鈥檚-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...
Scientists argue the criteria we use for diagnosing autism may need revision...
https://www.neurolingo.org/neurolingo-winter-2021 /ipnCategory:聽Academic conferences and symposia
RSS